3 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
Follow Hemay005: new trials by email Literature Review of Hemay005 trials Research Report on Hemay005
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD Hemay005 tablets, Roflumilast Oral Tablet, Placebo tablet - COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Not yet recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 120 | 2026-01-01 | 2026-01-02 |
| A Study of Hemay005 in Adult With Atopic Dermatitis Hemay005 - Hemay005, Atopic Dermatitis | Phase 2 | Completed | Ganzhou Hemay Pharmaceutical Co., Ltd | 79 | 2022-11-24 | 2024-03-01 |
| Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis Hemay005 tablets, Hemay005 placebo tablets - Moderate to Severe Ulcerative Colitis | Phase 2 | Active not recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 92 | 2022-11-08 | 2026-04-03 |
| Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis Hemay005 - Active Ankylosing Spondylitis | Phase 2 | Completed | Tianjin Hemay Pharmaceutical Co., Ltd | 90 | 2022-08-05 | 2024-01-11 |
| A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease Hemay005, Placebo - Behçet Disease | Phase 2 | Terminated | Tianjin Hemay Pharmaceutical Co., Ltd | 89 | 2020-11-30 | 2022-06-21 |
| Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis 15mg Hemay005, Placebos - Psoriasis | Phase 2 | Completed | Tianjin Hemay Pharmaceutical Co., Ltd | 216 | 2019-05-30 | 2021-10-13 |
Behcet Syndrome (1) · Dermatitis, Atopic (1) · Psoriasis (1) · Pulmonary Disease, Chronic Obstructive (1)
Ganzhou Hemay Pharmaceutical Co., Ltd (3) · Tianjin Hemay Pharmaceutical Co., Ltd (3)
China (6)
Min Zheng, Dr (1) · Shutian Zhang, MD (1) · Xiaofeng Zeng, M.D (1)